×
About 12,683 results

ALLMedicine™ Cholangitis Center

Research & Reviews  6,025 results

Post-COVID-19 Cholangiopathy: A Novel Entity.
https://doi.org/10.14309/ajg.0000000000001154
The American Journal of Gastroenterology; Roth NC, Kim A et. al.

Jan 19th, 2021 - Liver chemistry abnormalities are a frequent manifestation of coronavirus disease 2019 (COVID-19) but are usually transient and resolve with disease resolution. We describe the clinical course and histologic features of 3 adults who developed prol...

Enoxacin upregulates microRNA biogenesis and downregulates cytotoxic CD8 T cell functio...
https://doi.org/10.1002/hep.31724
Hepatology (Baltimore, Md.); Itoh A, Adams D et. al.

Jan 19th, 2021 - Primary biliary cholangitis (PBC) is a prototypical organ specific autoimmune disease, mediated by autoreactive T cell attack and destruction of cholangiocytes. Despite the clear role of autoimmunity in PBC, immune-directed therapies have failed t...

Is UDCA really a post-transplant panacea?
https://doi.org/10.1002/lt.25989
Liver Transplantation : Official Publication of the Ameri... Levy C, Sultan S

Jan 19th, 2021 - Recurrent primary biliary cholangitis (rPBC) occurs in up to 53% of LT recipients transplanted for PBC and negatively impacts long term graft (Hazard ratio 2.01) and patient survival (hazard ratio 1.72)(1). In multiple cohort studies, use of ursod...

Successful non-directed living liver donor transplant for an infant with biliary atresi...
https://doi.org/10.1111/petr.13816
Pediatric Transplantation; Feldman AG, Adams MA et. al.

Jan 18th, 2021 - Amidst the coronavirus (COVID-19) pandemic, the American Society for Transplant Surgeons has recommended that only urgent liver transplant with deceased donors should occur. However, young pediatric candidates rely on living donors for lifesaving ...

see more →

Guidelines  49 results

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With...
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.

Jul 15th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and managem...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691863
Gut Chapman MH, Thorburn D et. al.

Jun 3rd, 2019 - These guidelines on the management of primary sclerosing cholangitis (PSC) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included medical representatives from hepatology and gastroenter...

ACR Appropriateness Criteria® Radiologic Management of Biliary Obstruction.
https://doi.org/10.1016/j.jacr.2019.02.020
Journal of the American College of Radiology : JACR; , Fairchild AH et. al.

May 5th, 2019 - Biliary obstruction is a serious condition that can occur in the setting of both benign and malignant pathologies. In the setting of acute cholangitis, biliary decompression can be lifesaving; for patients with cancer who are receiving chemotherap...

ASGE guideline on the role of endoscopy in the evaluation and management of choledochol...
https://doi.org/10.1016/j.gie.2018.10.001
Gastrointestinal Endoscopy; , Buxbaum JL et. al.

Apr 13th, 2019 - Each year choledocholithiasis results in biliary obstruction, cholangitis, and pancreatitis in a significant number of patients. The primary treatment, ERCP, is minimally invasive but associated with adverse events in 6% to 15%. This American Soci...

Clinical practice guidelines for IgG4-related sclerosing cholangitis.
https://doi.org/10.1002/jhbp.596
Journal of Hepato-biliary-pancreatic Sciences; Kamisawa T, Nakazawa T et. al.

Dec 23rd, 2018 - IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria o...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  6,253 results

Post-COVID-19 Cholangiopathy: A Novel Entity.
https://doi.org/10.14309/ajg.0000000000001154
The American Journal of Gastroenterology; Roth NC, Kim A et. al.

Jan 19th, 2021 - Liver chemistry abnormalities are a frequent manifestation of coronavirus disease 2019 (COVID-19) but are usually transient and resolve with disease resolution. We describe the clinical course and histologic features of 3 adults who developed prol...

Enoxacin upregulates microRNA biogenesis and downregulates cytotoxic CD8 T cell functio...
https://doi.org/10.1002/hep.31724
Hepatology (Baltimore, Md.); Itoh A, Adams D et. al.

Jan 19th, 2021 - Primary biliary cholangitis (PBC) is a prototypical organ specific autoimmune disease, mediated by autoreactive T cell attack and destruction of cholangiocytes. Despite the clear role of autoimmunity in PBC, immune-directed therapies have failed t...

Is UDCA really a post-transplant panacea?
https://doi.org/10.1002/lt.25989
Liver Transplantation : Official Publication of the Ameri... Levy C, Sultan S

Jan 19th, 2021 - Recurrent primary biliary cholangitis (rPBC) occurs in up to 53% of LT recipients transplanted for PBC and negatively impacts long term graft (Hazard ratio 2.01) and patient survival (hazard ratio 1.72)(1). In multiple cohort studies, use of ursod...

Successful non-directed living liver donor transplant for an infant with biliary atresi...
https://doi.org/10.1111/petr.13816
Pediatric Transplantation; Feldman AG, Adams MA et. al.

Jan 18th, 2021 - Amidst the coronavirus (COVID-19) pandemic, the American Society for Transplant Surgeons has recommended that only urgent liver transplant with deceased donors should occur. However, young pediatric candidates rely on living donors for lifesaving ...

see more →

News  325 results

Gut Microbiome Altered in Primary Sclerosing Cholangitis
https://www.medscape.com/viewarticle/943877

Jan 11th, 2021 - NEW YORK (Reuters Health) - The gut microbiomes of patients with primary sclerosing cholangitis (PSC) show major functional differences from those of healthy controls (HCs), new findings show. Individuals with PSC had fewer genes involved in synth...

GLIMMER of Hope for Itch in Primary Biliary Cholangitis
https://www.staging.medscape.com/viewarticle/941007

Nov 13th, 2020 - Patients with primary biliary cholangitis experienced rapid improvements in itch and quality of life after treatment with linerixibat in a randomized placebo-controlled trial of the safety, efficacy, and tolerability of the small-molecule drug. Mo...

GLIMMER of Hope for Itch in Primary Biliary Cholangitis
https://www.medscape.com/viewarticle/941007

Nov 13th, 2020 - Patients with primary biliary cholangitis experienced rapid improvements in itch and quality of life after treatment with linerixibat in a randomized placebo-controlled trial of the safety, efficacy, and tolerability of the small-molecule drug. Mo...

Bezafibrate Improves Itch in Patients With Cholestatic Diseases
https://www.staging.medscape.com/viewarticle/940403

Nov 4th, 2020 - (Reuters Health) - Patients with moderate to severe primary or secondary sclerosing cholangitis experienced greater reduction of pruritis with bezafibrate than with placebo, a small trial found. Researchers examined data on 44 patients with primar...

Bezafibrate Improves Itch in Patients With Cholestatic Diseases
https://www.medscape.com/viewarticle/940403

Nov 4th, 2020 - (Reuters Health) - Patients with moderate to severe primary or secondary sclerosing cholangitis experienced greater reduction of pruritis with bezafibrate than with placebo, a small trial found. Researchers examined data on 44 patients with primar...

see more →

Patient Education  29 results see all →